Heat shock proteins and cancer therapy: The trail grows hotter!

John R. Subjeck; Elizabeth A. Repasky

doi:10.18632/oncotarget.294

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Editorial Comments:

Heat shock proteins and cancer therapy: The trail grows hotter!

John R. Subjeck and Elizabeth A. Repasky _

PDF | HTML | How to cite | Order a Reprint

Oncotarget. 2011; 2:433-434. https://doi.org/10.18632/oncotarget.294

Metrics: PDF 2057 views | HTML 2596 views | ?

Abstract

Commentary on: Neznanov et al. Oncotarget. 2011;2(3):209-21.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 294

Subscribe to TOC Alerts

Editorial Comments:

Heat shock proteins and cancer therapy: The trail grows hotter!

Abstract